Amgen To Shell Out $669M For Turkish Drugmaker
California biotech giant Amgen Inc. is grabbing a majority stake in Mustafa Nevzat Pharmaceuticals, a family-owned Turkish maker of cancer medicines and a vital portal to the Middle Eastern country's drug...To view the full article, register now.
Already a subscriber? Click here to view full article